Corrigendum to "Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab" [Lung Cancer 115 (2018) 71–74]. (December 2018) - Sato, Koichi; Akamatsu, Hiroaki; Murakami, Eriko; Sasaki, Seigo; Kanai, Kuninobu; Hayata, Atsushi; Tokudome, Nahomi; Akamatsu, Keiichiro; Koh, Yasuhiro; Ueda, Hiroki; Nakanishi, Masanori; Yamamoto, Nobuyuki